| 1 |
27976373 | Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation. | 2017 Mar |
1 |
| 2 |
29228586 | Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma. | 2017 Nov 14 |
2 |
| 3 |
25646015 | Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth. | 2015 Apr |
1 |
| 4 |
24398427 | Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice. | 2014 Feb |
1 |
| 5 |
25149535 | AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells. | 2014 Aug 30 |
1 |
| 6 |
23531921 | Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo. | 2013 Mar |
6 |
| 7 |
22355274 | Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology. | 2012 Jan |
1 |
| 8 |
21164517 | The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival. | 2011 Mar |
1 |
| 9 |
22027691 | Therapeutic potential of AZD1480 for the treatment of human glioblastoma. | 2011 Dec |
2 |